Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cazigeran is an oral multivitamin and mineral supplement developed by Cazi Química Farmacêutica. It is formulated as a combination of potassium aspartate, magnesium aspartate, racealfatocoferol acetate (vitamin E), thiamine hydrochloride (vitamin B1), riboflavin (vitamin B2), and pyridoxine hydrochloride (vitamin B6). Cazigeran is indicated for the treatment of physical and mental exhaustion, fatigue, asthenia, nutritional deficiencies, and as a supportive therapy during convalescence, in elderly patients, or those on restrictive diets. The aspartate salts help restore electrolyte balance and combat muscle fatigue, while the B-complex vitamins and vitamin E support cellular metabolism, energy production, and provide antioxidant protection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cazigeran.